Unknown

Dataset Information

0

Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2-mutated myeloproliferative neoplasms.


ABSTRACT: High mobility group AT-hook 2 (HMGA2) is an architectural transcription factor that is negatively regulated by let-7 microRNA through binding to it's 3'-untranslated region. Transgenic mice expressing Hmga2 with a truncation of its 3'-untranslated region has been shown to exhibit a myeloproliferative phenotype. To decipher the let-7-HMGA2 axis in myeloproliferative neoplasms, we employed an in vitro model supplemented with clinical correlation. Ba/F3 cells with inducible JAK2V617F expression (Ton.JAK2.V617F cells) showed upregulation of HMGA2 with concurrent let-7a repression. Ton.JAK2.V617F cells treated with a let-7a inhibitor exhibited further escalation of Hmga2 expression, while a let-7a mimic diminished the Hmga2 transcript level. Hmga2 overexpression conferred JAK2-mutated cells with a survival advantage through inhibited apoptosis. A pan-JAK inhibitor, INC424, increased the expression of let-7a, downregulated the level of Hmga2, and led to increased apoptosis in Ton.JAK2.V617F cells in a dose-dependent manner. In samples from 151 patients with myeloproliferative neoplasms, there was a modest inverse correlation between the expression levels of let-7a and HMGA2 Overexpression of HMGA2 was detected in 29 (19.2%) of the cases, and it was more commonly seen in patients with essential thrombocythemia than in those with polycythemia vera (26.9% vs 12.7%, P=0.044). Patients with upregulated HMGA2 showed an increased propensity for developing major thrombotic events, and they were more likely to harbor one of the 3 driver myeloproliferative neoplasm mutations in JAK2, MPL and CALR Our findings suggest that, in a subset of myeloproliferative neoplasm patients, the let-7-HMGA2 axis plays a prominent role in the pathogenesis of the disease that leads to unique clinical phenotypes.

SUBMITTER: Chen CC 

PROVIDER: S-EPMC5394969 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in <i>JAK2</i>-mutated myeloproliferative neoplasms.

Chen Chih-Cheng CC   You Jie-Yu JY   Lung Jrhau J   Huang Cih-En CE   Chen Yi-Yang YY   Leu Yu-Wei YW   Ho Hsing-Ying HY   Li Chian-Pei CP   Lu Chang-Hsien CH   Lee Kuan-Der KD   Hsu Chia-Chen CC   Gau Jyh-Pyng JP  

Haematologica 20170105 3


High mobility group AT-hook 2 (HMGA2) is an architectural transcription factor that is negatively regulated by <i>let-7</i> microRNA through binding to it's 3'-untranslated region. Transgenic mice expressing <i>Hmga2</i> with a truncation of its 3'-untranslated region has been shown to exhibit a myeloproliferative phenotype. To decipher the <i>let-7-HMGA2</i> axis in myeloproliferative neoplasms, we employed an <i>in vitro</i> model supplemented with clinical correlation. Ba/F3 cells with induci  ...[more]

Similar Datasets

| S-EPMC5728313 | biostudies-literature
| S-EPMC3145114 | biostudies-literature
| S-EPMC10952374 | biostudies-literature
| S-EPMC8874480 | biostudies-literature
| S-EPMC4406395 | biostudies-literature
2020-07-08 | GSE154025 | GEO
| S-EPMC8870427 | biostudies-literature
| S-EPMC5510786 | biostudies-literature
| S-EPMC5176249 | biostudies-literature
| S-EPMC8961666 | biostudies-literature